CDCP1 and prostate cancer: We next assessed the level of cell surface CDCP1 in 49 cell lines from a diverse range of adenocarcinomas, including seven from kidney, nine from lung, four from colorectal, 20 from ovarian and two from prostate cancer and seven from PDAC.